Cargando…
Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms
Incomplete delivery to the target cells is an obstacle for successful gene therapy approaches. Here we show unexpected effects of incomplete targeting, by demonstrating how heterogeneous inhibition of a growth promoting signaling pathway promotes tissue hyperplasia. We studied the function of the ly...
Autores principales: | Zhang, Yan, Ulvmar, Maria H., Stanczuk, Lukas, Martinez-Corral, Ines, Frye, Maike, Alitalo, Kari, Mäkinen, Taija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882855/ https://www.ncbi.nlm.nih.gov/pubmed/29615616 http://dx.doi.org/10.1038/s41467-018-03692-0 |
Ejemplares similares
-
Pdgfrb‐Cre targets lymphatic endothelial cells of both venous and non‐venous origins
por: Ulvmar, Maria H., et al.
Publicado: (2016) -
Heterogeneity in the lymphatic vascular system and its origin
por: Ulvmar, Maria H., et al.
Publicado: (2016) -
Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth
por: Urner, Sofia, et al.
Publicado: (2018) -
Transcription factor FOXP2 is a flow‐induced regulator of collecting lymphatic vessels
por: Hernández Vásquez, Magda N, et al.
Publicado: (2021) -
Lymphatic Vessels as Targets of Tumor Therapy?
por: Karpanen, Terhi, et al.
Publicado: (2001)